Neurology Today in 5 Por: Neurology Today Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue. 100 episodios disponibles Latest episodes of the podcast Neurology Today in 5 Mostrando página 2 de 5 Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment 06/02/2025 Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024. 16/01/2025 Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players. 02/01/2025 Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty 19/12/2024 3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration 05/12/2024 Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer's 21/11/2024 Fever prevention and stroke, environmental toxins and Parkinson's, cholesterol overload and ALS progression 07/11/2024 Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder 17/10/2024 Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke 03/10/2024 Brain circuit underlying placebo pain relief, common Parkinson's gene variants, blood biomarker testing for Alzheimer's 19/09/2024 Alzheimer's diagnosis criteria, AI and Parkinson's severity, neurotoxicity of racism 05/09/2024 Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice 15/08/2024 Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer 31/07/2024 Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab 18/07/2024 Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology 04/07/2024 When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs. 20/06/2024 Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics 06/06/2024 Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers 16/05/2024 Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies 02/05/2024 ME/CFS and long COVID; negative outcomes for ALS drug; donanemab 18/04/2024 « Primera ‹ Anterior 1 2 3 4 5 Siguiente › Última » Share Facebook Twitter LinkedIn